BeOne Medicines AG Stock Forecast

Stock Price Forecast

The 11 analysts that cover BeOne Medicines AG stock have a consensus rating of "Strong Buy" and an average price target of $377.91, which forecasts a 31.89% increase in the stock price over the next year. The lowest target is $290 and the highest is $425.

Price Target: $377.91 (+31.89%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$290	$377.91	$396	$425
Change	+1.21%	+31.89%	+38.20%	+48.32%

Analyst Ratings

The average analyst rating for BeOne Medicines AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	4	4	4	4	4
Buy	8	8	8	8	8	6
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	12	12	12	12	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Faisal Khurshid Jefferies	Jefferies	Strong Buy → Hold Downgrades $420 → $290	Strong Buy → Hold	Downgrades	$420 → $290	+1.21%	Mar 16, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $417 → $425	Buy	Maintains	$417 → $425	+48.32%	Feb 27, 2026
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $400 → $412	Strong Buy	Maintains	$400 → $412	+43.78%	Feb 27, 2026
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Maintains $400 → $410	Strong Buy	Maintains	$400 → $410	+43.09%	Feb 27, 2026
Peter Lawson Barclays	Barclays	Buy Maintains $394 → $405	Buy	Maintains	$394 → $405	+41.34%	Feb 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

45.91B

from 5.34B

759.19%

from 5.34B

Revenue Next Year

52.57B

from 45.91B

14.51%

from 45.91B

EPS This Year

3.45

from 2.47

39.49%

from 2.47

EPS Next Year

4.94

from 3.45

43.45%

from 3.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.18B	1.42B	2.46B	3.81B	5.34B	45.91B	52.57B
Revenue Growth	280.83%	20.37%	73.65%	54.97%	40.23%	759.19%	14.51%
EPS	-15.71	-19.43	-8.45	-6.12	2.47	3.45	4.94
EPS Growth	-	-	-	-	-	39.49%	43.45%
Forward PE	-	-	-	-	-	83.16	57.97
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	48.9B	59.8B
Avg	45.9B	52.6B
Low	42.0B	46.6B

Revenue Growth

Revenue Growth	2026	2027
High	815.9%	30.4%
Avg	759.2%	14.5%
Low	686.5%	1.6%

EPS Forecast

EPS	2026	2027
High	4.40	7.07
Avg	3.45	4.94
Low	2.90	2.93

EPS Growth

EPS Growth	2026	2027
High	77.9%	105.1%
Avg	39.5%	43.5%
Low	17.4%	-15.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.